The Centers for Disease Control and Prevention (CDC) said on April 14 that it learned of a seventh woman who developed a rare and severe type of blood clot after receiving the Johnson & Johnson (J&J) COVID-19 vaccine. The seventh possible patient was identified as a 28-year-old woman, as the Advisor...